inflammation after stopping glp 1 Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss Glucagon-like peptide-1: a multi-faceted anti-inflammatory
Description
However, this is unlikely, as Ex4 reduces intravenous self-administration of alcohol in male mice (Sorensen et al., 2016) and the GLP-1R agonist does not reduce water intake
Hormonal signaling has stabilized
Most researchers who arrive at this comparison already have experience with one GLP compound and are evaluating whether the additional receptor targets of GLP-2(Tirz) or GLP-3(Reta) meaningfully change the research outcomes they are tracking
In the pivotal SURPASS-2 trial (n=1,879), tirzepatide at all doses (5 mg, 10 mg, 15 mg) demonstrated both non-inferiority and superiority to semaglutide 1 mg injection for A1C reduction (-2.01% to -2.30% vs -1.86%) and body weight loss (-7.6 to -12.4 kg vs -5.7 kg)
PlexusDx compounded semaglutide and tirzepatide range $149/mo from licensed 503A pharmacies
